Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster
Isabell Wagenhäuser, Julia Reusch, Alexander Gabel, Lukas B. Krone, Oliver Kurzai, Nils Petri, Manuel Krone
Topics & Concepts
Booster (rocketry)Bivalent (engine)Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVaccinationVirologyMedicineChemistryPhysicsInfectious disease (medical specialty)Internal medicineOutbreakAstronomyOrganic chemistryDiseaseMetalSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing